# loanDepot, Inc.: financial statements, quarterly

LDI · NYSE · CIK 1831631 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ldi.md) · [Financials](/companies/ldi/financials.md) · [Filings](/companies/ldi/filings.md) · [Insiders](/companies/ldi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ldi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [266](/filings/0001831631-24-000285.md) | [229 d](/filings/0001831631-26-000028.md) | [223](/filings/0001831631-25-000083.md) | [265](/filings/0001831631-25-000154.md) | [315](/filings/0001831631-25-000221.md) | [257 d](/filings/0001831631-26-000028.md) | [274](/filings/0001831631-26-000061.md) | [283](/filings/0001831631-26-000086.md) | [323](/filings/0001831631-25-000221.md) | [310 d](/filings/0001831631-26-000028.md) | [286](/filings/0001831631-26-000061.md) | [337](/filings/0001831631-26-000086.md) |
| Interest expense | $m | [34.6](/filings/0001831631-23-000308.md) | [38.5 d](/filings/0001831631-24-000063.md) | [31.7](/filings/0001831631-24-000112.md) | [35.7](/filings/0001831631-24-000202.md) | [45.1](/filings/0001831631-25-000221.md) | [43.9 d](/filings/0001831631-26-000028.md) | [43.3](/filings/0001831631-26-000061.md) | [44.0](/filings/0001831631-26-000086.md) | [44.3](/filings/0001831631-25-000221.md) | [43.7 d](/filings/0001831631-26-000028.md) | [43.1](/filings/0001831631-26-000061.md) | [41.9](/filings/0001831631-26-000086.md) |
| Income tax | $m | [(5.2)](/filings/0001831631-24-000285.md) | [(14.2) d](/filings/0001831631-26-000028.md) | [(13.7)](/filings/0001831631-25-000083.md) | [(11.3)](/filings/0001831631-25-000154.md) | [0.9](/filings/0001831631-25-000221.md) | [(16.7) d](/filings/0001831631-26-000028.md) | [(5.4)](/filings/0001831631-26-000061.md) | [(7.1)](/filings/0001831631-26-000086.md) | [(1.6)](/filings/0001831631-25-000221.md) | [1.0 d](/filings/0001831631-26-000028.md) | [(0.2)](/filings/0001831631-26-000061.md) | [0.0](/filings/0001831631-26-000086.md) |
| Net income | $m | [(16.6)](/filings/0001831631-24-000285.md) | [(27.2) d](/filings/0001831631-26-000028.md) | [(34.3)](/filings/0001831631-25-000083.md) | [(32.2)](/filings/0001831631-25-000154.md) | [1.4](/filings/0001831631-25-000221.md) | [(33.2) d](/filings/0001831631-26-000028.md) | [(21.9)](/filings/0001831631-26-000061.md) | [(13.4)](/filings/0001831631-26-000086.md) | [(4.9)](/filings/0001831631-25-000221.md) | [(22.5) d](/filings/0001831631-26-000028.md) | [(37.5)](/filings/0001831631-26-000061.md) | [(4.5)](/filings/0001831631-26-000086.md) |
| Diluted EPS | $ per share | [(0.09)](/filings/0001831631-24-000285.md) | not reported | [(0.19)](/filings/0001831631-24-000112.md) | [(0.18)](/filings/0001831631-24-000202.md) | [0.01](/filings/0001831631-24-000285.md) | not reported | not reported | [(0.06)](/filings/0001831631-26-000086.md) | not reported | not reported | not reported | [(0.02)](/filings/0001831631-26-000086.md) |
| Basic EPS | $ per share | [(0.09)](/filings/0001831631-24-000285.md) | not reported | [(0.19)](/filings/0001831631-24-000112.md) | [(0.18)](/filings/0001831631-24-000202.md) | [0.01](/filings/0001831631-24-000285.md) | not reported | not reported | [(0.06)](/filings/0001831631-26-000086.md) | not reported | not reported | not reported | [(0.02)](/filings/0001831631-26-000086.md) |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [717](/filings/0001831631-23-000308.md) | [661](/filings/0001831631-26-000028.md) | [604](/filings/0001831631-25-000083.md) | [533](/filings/0001831631-25-000154.md) | [483](/filings/0001831631-25-000221.md) | [422](/filings/0001831631-26-000028.md) | [371](/filings/0001831631-26-000061.md) | [409](/filings/0001831631-26-000086.md) | [459](/filings/0001831631-25-000221.md) | [337](/filings/0001831631-26-000086.md) | [277](/filings/0001831631-26-000061.md) | [229](/filings/0001831631-26-000086.md) |
| Total assets | $m | [6,079](/filings/0001831631-23-000308.md) | [6,151](/filings/0001831631-25-000023.md) | [6,193](/filings/0001831631-24-000112.md) | [5,943](/filings/0001831631-24-000202.md) | [6,418](/filings/0001831631-24-000285.md) | [6,344](/filings/0001831631-26-000028.md) | [6,417](/filings/0001831631-25-000083.md) | [6,209](/filings/0001831631-25-000154.md) | [6,245](/filings/0001831631-25-000221.md) | [6,858](/filings/0001831631-26-000086.md) | [7,247](/filings/0001831631-26-000061.md) | [6,697](/filings/0001831631-26-000086.md) |
| Total liabilities | $m | [5,310](/filings/0001831631-23-000308.md) | [5,447](/filings/0001831631-25-000023.md) | [5,556](/filings/0001831631-24-000112.md) | [5,364](/filings/0001831631-24-000202.md) | [5,826](/filings/0001831631-24-000285.md) | [5,837](/filings/0001831631-26-000028.md) | [5,947](/filings/0001831631-25-000083.md) | [5,770](/filings/0001831631-25-000154.md) | [5,812](/filings/0001831631-25-000221.md) | [6,472](/filings/0001831631-26-000086.md) | [6,909](/filings/0001831631-26-000061.md) | [6,364](/filings/0001831631-26-000086.md) |
| Long-term debt | $m | [2,206](/filings/0001831631-23-000308.md) | [2,274](/filings/0001831631-25-000023.md) | [2,314](/filings/0001831631-24-000112.md) | [1,975](/filings/0001831631-24-000202.md) | [1,957](/filings/0001831631-24-000285.md) | [2,027](/filings/0001831631-26-000028.md) | [2,017](/filings/0001831631-25-000083.md) | [2,062](/filings/0001831631-25-000154.md) | [2,091](/filings/0001831631-25-000221.md) | [2,100](/filings/0001831631-26-000086.md) | [2,115](/filings/0001831631-26-000061.md) | [2,130](/filings/0001831631-26-000086.md) |
| Shareholders' equity | $m | [769](/filings/0001831631-24-000285.md) | [704](/filings/0001831631-26-000028.md) | [637](/filings/0001831631-25-000154.md) | [579](/filings/0001831631-25-000221.md) | [592](/filings/0001831631-25-000221.md) | [507](/filings/0001831631-26-000086.md) | [469](/filings/0001831631-26-000086.md) | [439](/filings/0001831631-26-000086.md) | [433](/filings/0001831631-25-000221.md) | [386](/filings/0001831631-26-000086.md) | [337](/filings/0001831631-26-000086.md) | [333](/filings/0001831631-26-000086.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [163 d](/filings/0001831631-24-000285.md) | [(205) d](/filings/0001831631-26-000028.md) | [(279)](/filings/0001831631-25-000083.md) | [(278) d](/filings/0001831631-25-000154.md) | [(349) d](/filings/0001831631-25-000221.md) | [47.7 d](/filings/0001831631-26-000028.md) | [(177)](/filings/0001831631-26-000061.md) | [70.6 d](/filings/0001831631-26-000086.md) | [37.3 d](/filings/0001831631-25-000221.md) | [(639) d](/filings/0001831631-26-000028.md) | [(169)](/filings/0001831631-26-000061.md) | [520 d](/filings/0001831631-26-000086.md) |
| Capital expenditure | $m | [4.8 d](/filings/0001831631-24-000285.md) | [4.3 d](/filings/0001831631-26-000028.md) | [4.8](/filings/0001831631-25-000083.md) | [7.4 d](/filings/0001831631-25-000154.md) | [7.3 d](/filings/0001831631-25-000221.md) | [6.9 d](/filings/0001831631-26-000028.md) | [6.8](/filings/0001831631-26-000061.md) | [6.2 d](/filings/0001831631-26-000086.md) | [4.7 d](/filings/0001831631-25-000221.md) | [9.3 d](/filings/0001831631-26-000028.md) | [7.8](/filings/0001831631-26-000061.md) | [9.4 d](/filings/0001831631-26-000086.md) |
| Dividends paid | $m | [0.6 d](/filings/0001831631-24-000285.md) | [0.7 d](/filings/0001831631-26-000028.md) | [0.9](/filings/0001831631-25-000083.md) | [0.5 d](/filings/0001831631-25-000154.md) | [1.5 d](/filings/0001831631-25-000221.md) | [0.4 d](/filings/0001831631-26-000028.md) | [2.1](/filings/0001831631-26-000061.md) | [1.1 d](/filings/0001831631-26-000086.md) | [(0.0) d](/filings/0001831631-25-000221.md) | [(0.7) d](/filings/0001831631-26-000028.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q2 FY2025 (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [130](/filings/0001831631-22-000326.md) | [139](/filings/0001831631-23-000154.md) | [154](/filings/0001831631-23-000258.md) | [162](/filings/0001831631-23-000308.md) | [171](/filings/0001831631-24-000112.md) | [174](/filings/0001831631-24-000202.md) | [176](/filings/0001831631-24-000285.md) | [325](/filings/0001831631-24-000112.md) | [182](/filings/0001831631-24-000202.md) | [333](/filings/0001831631-24-000285.md) | [208](/filings/0001831631-26-000086.md) | [232](/filings/0001831631-26-000086.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.